|
Sen. Dale A. Righter
Filed: 4/5/2019
| | 10100SB1105sam001 | | LRB101 06383 KTG 59330 a |
|
|
1 | | AMENDMENT TO SENATE BILL 1105
|
2 | | AMENDMENT NO. ______. Amend Senate Bill 1105 by replacing |
3 | | everything after the enacting clause with the following:
|
4 | | "Section 5. The Pediatric Palliative Care Act is amended by |
5 | | changing Sections 5, 10, 15, 20, 25, 30, 35, 40, and 45 and by |
6 | | adding Section 37 as follows: |
7 | | (305 ILCS 60/5)
|
8 | | Sec. 5. Legislative findings. The General Assembly finds as |
9 | | follows: |
10 | | (1) Each year, approximately 1,500 1,185 Illinois |
11 | | children are diagnosed with a serious illness potentially |
12 | | life-limiting illness . |
13 | | (2) There are many barriers to the provision of |
14 | | pediatric palliative services, the most significant of |
15 | | which include the following: (i) challenges in predicting |
16 | | life expectancy; (ii) the reluctance of families and |
|
| | 10100SB1105sam001 | - 2 - | LRB101 06383 KTG 59330 a |
|
|
1 | | professionals to acknowledge a child's incurable |
2 | | condition; and (iii) the lack of an appropriate, |
3 | | pediatric-focused reimbursement structure leading to |
4 | | insufficient community-based resources. |
5 | | (3) Community-based pediatric palliative services have |
6 | | been shown to keep children out of the hospital by managing |
7 | | many symptoms in the home setting, thereby improving |
8 | | childhood quality of life while maintaining budget |
9 | | neutrality. It is tremendously difficult for physicians to |
10 | | prognosticate pediatric life expectancy due to the |
11 | | resiliency of children. In addition, parents are rarely |
12 | | prepared to cease curative efforts in order to receive |
13 | | hospice or palliative care. Community-based pediatric |
14 | | palliative services, however, keep children out of the |
15 | | hospital by managing many symptoms in the home setting, |
16 | | thereby improving childhood quality of life while |
17 | | maintaining budget neutrality.
|
18 | | (4) Pediatric palliative programming can, and should, |
19 | | be administered in a cost neutral fashion. Community-based |
20 | | pediatric palliative care allows for children and families |
21 | | to receive pain and symptom management and psychosocial |
22 | | support in the comfort of the home setting, thereby |
23 | | avoiding excess spending for emergency room visits and |
24 | | certain hospitals. The National Hospice and Palliative |
25 | | Care Organization's pediatric task force reported during |
26 | | 2001 that the average cost per child per year, cared for |
|
| | 10100SB1105sam001 | - 3 - | LRB101 06383 KTG 59330 a |
|
|
1 | | primarily at home, receiving comprehensive palliative and |
2 | | life prolonging services concurrently, is $16,177, |
3 | | significantly less than the $19,000 to $48,000 per child |
4 | | per year when palliative programs are not utilized.
|
5 | | (Source: P.A. 96-1078, eff. 7-16-10.) |
6 | | (305 ILCS 60/10)
|
7 | | Sec. 10. Definitions Definition . In this Act : , |
8 | | "Department" means the Department of Healthcare and Family |
9 | | Services.
|
10 | | "Palliative care" means care focused on expert assessment |
11 | | and management of pain and other symptoms, assessment and |
12 | | support of caregiver needs, and coordination of care. |
13 | | Palliative care attends to the physical, functional, |
14 | | psychological, practical, and spiritual consequences of a |
15 | | serious illness. It is a person-centered and family-centered |
16 | | approach to care, providing people living with serious illness |
17 | | relief from the symptoms and stress of an illness. Through |
18 | | early integration into the care plan for the seriously ill, |
19 | | palliative care improves quality of life for the patient and |
20 | | the family. Palliative care can be offered in all care settings |
21 | | and at any stage in a serious illness through collaboration of |
22 | | many types of care providers. |
23 | | "Serious illness" means a health condition that carries a |
24 | | high risk of mortality and either negatively impacts a person's |
25 | | daily function or quality of life or excessively strains their |
|
| | 10100SB1105sam001 | - 4 - | LRB101 06383 KTG 59330 a |
|
|
1 | | caregiver. |
2 | | (Source: P.A. 96-1078, eff. 7-16-10.) |
3 | | (305 ILCS 60/15)
|
4 | | Sec. 15. Pediatric palliative care pilot program. The |
5 | | Department shall develop a pediatric palliative care pilot |
6 | | program under which a qualifying child as defined in Section 25 |
7 | | may receive community-based pediatric palliative care from a |
8 | | trained interdisciplinary team and may also choose to continue |
9 | | while continuing to pursue aggressive curative or |
10 | | disease-directed treatments for a serious potentially |
11 | | life-limiting illness under the benefits available under |
12 | | Article V of the Illinois Public Aid Code.
|
13 | | (Source: P.A. 96-1078, eff. 7-16-10.) |
14 | | (305 ILCS 60/20)
|
15 | | Sec. 20. Federal waiver or State Plan amendment. If |
16 | | applicable, the The Department shall submit the necessary |
17 | | application to the federal Centers for Medicare and Medicaid |
18 | | Services for a waiver or State Plan amendment to implement the |
19 | | pilot program described in this Act. If the application is in |
20 | | the form of a State Plan amendment, the State Plan amendment |
21 | | shall be filed prior to December 31, 2010. If the Department |
22 | | does not submit a State Plan amendment prior to December 31, |
23 | | 2010, the pilot program shall be created utilizing a waiver |
24 | | authority. The waiver request shall be included in any |
|
| | 10100SB1105sam001 | - 5 - | LRB101 06383 KTG 59330 a |
|
|
1 | | appropriate waiver application renewal submitted prior to |
2 | | December 31, 2011, or shall be submitted as an independent |
3 | | 1915(c) Home and Community Based Medicaid Waiver within that |
4 | | same time period. After federal approval is secured, the |
5 | | Department shall implement the waiver or State Plan amendment |
6 | | within 12 months of the date of approval. The Department shall |
7 | | not draft any rules in contravention of this timetable for |
8 | | program development and implementation. By federal |
9 | | requirement, the application for a 1915 (c) Medicaid waiver |
10 | | program must demonstrate cost neutrality per the formula laid |
11 | | out by the Centers for Medicare and Medicaid Services. The |
12 | | Department shall not draft any rules in contravention of this |
13 | | timetable for pilot program development and implementation. |
14 | | This pilot program shall be implemented only to the extent that |
15 | | federal financial participation is available.
|
16 | | (Source: P.A. 96-1078, eff. 7-16-10.) |
17 | | (305 ILCS 60/25)
|
18 | | Sec. 25. Qualifying child. |
19 | | (a) For the purposes of this Act, a qualifying child is a |
20 | | person under 19 18 years of age who is enrolled in the medical |
21 | | assistance program under Article V of the Illinois Public Aid |
22 | | Code and suffers from a serious illness potentially |
23 | | life-limiting medical condition , as defined in subsection (b). |
24 | | A child who is enrolled in the pilot program prior to the age |
25 | | 19 18 may continue to receive services under the pilot program |
|
| | 10100SB1105sam001 | - 6 - | LRB101 06383 KTG 59330 a |
|
|
1 | | until the day before his or her twenty-first birthday.
|
2 | | (b) The Department, in consultation with interested |
3 | | stakeholders, shall determine the serious illnesses |
4 | | potentially life-limiting medical conditions that render a |
5 | | pediatric medical assistance recipient eligible for the pilot |
6 | | program under this Act. Such serious illnesses medical |
7 | | conditions shall include, but need not be limited to, the |
8 | | following: |
9 | | (1) Cancer (i) for which there is no known effective |
10 | | treatment, (ii) that does not respond to conventional |
11 | | protocol, (iii) that has progressed to an advanced stage, |
12 | | or (iv) where toxicities or other complications limit |
13 | | prohibit the administration of curative therapies. |
14 | | (2) End-stage lung disease, including but not limited |
15 | | to cystic fibrosis, that results in dependence on |
16 | | technology, such as mechanical ventilation. |
17 | | (3) Severe neurological conditions, including, but not |
18 | | limited to, hypoxic ischemic encephalopathy, acute brain |
19 | | injury, brain infections and inflammatory diseases, or |
20 | | irreversible severe alteration of mental status, with one |
21 | | of the following co-morbidities: (i) intractable seizures |
22 | | or (ii) brainstem failure to control breathing or other |
23 | | automatic physiologic functions. |
24 | | (4) Degenerative neuromuscular conditions, including, |
25 | | but not limited to, spinal muscular atrophy, Type I or II, |
26 | | or Duchenne Muscular Dystrophy, requiring technological |
|
| | 10100SB1105sam001 | - 7 - | LRB101 06383 KTG 59330 a |
|
|
1 | | support. |
2 | | (5) Genetic syndromes, such as Trisomy 13 or 18, where |
3 | | (i) it is more likely than not that the child will not live |
4 | | past 2 years of age or (ii) the child is severely |
5 | | compromised with no expectation of long-term survival. |
6 | | (6) Congenital or acquired end-stage heart disease, |
7 | | including but not limited to the following: (i) single |
8 | | ventricle disorders, including hypoplastic left heart |
9 | | syndrome; (ii) total anomalous pulmonary venous return, |
10 | | not suitable for curative surgical treatment; and (iii) |
11 | | heart muscle disorders (cardiomyopathies) without adequate |
12 | | medical or surgical treatments. |
13 | | (7) End-stage liver disease where (i) transplant is not |
14 | | a viable option or (ii) transplant rejection or failure has |
15 | | occurred. |
16 | | (8) End-stage kidney failure where (i) transplant is |
17 | | not a viable option or (ii) transplant rejection or failure |
18 | | has occurred. |
19 | | (9) Metabolic or biochemical disorders, including, but |
20 | | not limited to, mitochondrial disease, leukodystrophies, |
21 | | Tay-Sachs disease, or Lesch-Nyhan syndrome where (i) no |
22 | | suitable therapies exist or (ii) available treatments, |
23 | | including stem cell ("bone marrow") transplant, have |
24 | | failed. |
25 | | (10) Congenital or acquired diseases of the |
26 | | gastrointestinal system, such as "short bowel syndrome", |
|
| | 10100SB1105sam001 | - 8 - | LRB101 06383 KTG 59330 a |
|
|
1 | | where (i) transplant is not a viable option or (ii) |
2 | | transplant rejection or failure has occurred. |
3 | | (11) Congenital skin disorders, including but not |
4 | | limited to epidermolysis bullosa, where no suitable |
5 | | treatment exists.
|
6 | | (12) Any other serious illness that the Department |
7 | | determines to be appropriate. |
8 | | The definition of a serious illness life-limiting medical |
9 | | condition shall not include a definitive time period due to the |
10 | | difficulty and challenges of prognosticating life expectancy |
11 | | in children.
|
12 | | (Source: P.A. 96-1078, eff. 7-16-10.) |
13 | | (305 ILCS 60/30)
|
14 | | Sec. 30. Authorized providers. Providers authorized to |
15 | | deliver services under the pilot waiver program shall include |
16 | | licensed hospice agencies or home health agencies licensed to |
17 | | provide hospice care and will be subject to further criteria |
18 | | developed by the Department , in consultation with interested |
19 | | stakeholders, for provider participation. At a minimum, the |
20 | | participating provider must house a pediatric |
21 | | interdisciplinary team that includes : (i) a physician, acting |
22 | | as the program medical
director, who is board certified or |
23 | | board eligible in pediatrics or hospice and palliative |
24 | | medicine; (ii) a registered nurse; and (iii) a licensed social |
25 | | worker with a background in pediatric care a pediatric medical |
|
| | 10100SB1105sam001 | - 9 - | LRB101 06383 KTG 59330 a |
|
|
1 | | director, a nurse, and a licensed social worker . All members of |
2 | | the pediatric interdisciplinary team must meet criteria the |
3 | | Department may establish by rule, including demonstrated |
4 | | expertise in pediatric palliative care. submit to the |
5 | | Department proof of pediatric End-of-Life Nursing Education |
6 | | Curriculum (Pediatric ELNEC Training) or an equivalent.
|
7 | | (Source: P.A. 96-1078, eff. 7-16-10.) |
8 | | (305 ILCS 60/35)
|
9 | | Sec. 35. Interdisciplinary team; services. The Subject to |
10 | | federal approval for matching funds, the reimbursable services |
11 | | offered under the pilot program shall be provided by an |
12 | | interdisciplinary team, operating under the direction of a |
13 | | pediatric medical director, and shall include, but not be |
14 | | limited to, the following: |
15 | | (1) Pediatric nursing for pain and symptom management. |
16 | | (2) Expressive therapies (music or and art therapies) |
17 | | for age-appropriate counseling. |
18 | | (3) Client and family counseling (provided by a |
19 | | licensed social worker , licensed counselor, or |
20 | | non-denominational chaplain or spiritual counselor). |
21 | | (4) Respite care. |
22 | | (5) Bereavement services. |
23 | | (6) Case management.
|
24 | | (7) Any other services that the Department determines |
25 | | to be appropriate. |
|
| | 10100SB1105sam001 | - 10 - | LRB101 06383 KTG 59330 a |
|
|
1 | | (Source: P.A. 96-1078, eff. 7-16-10.) |
2 | | (305 ILCS 60/37 new) |
3 | | Sec. 37. Medicaid managed care organizations; technical |
4 | | assistance. The Department, in consultation with interested |
5 | | stakeholders, shall establish standards for and provide |
6 | | technical assistance to managed care organizations, as defined |
7 | | in Section 5-30.1 of the Illinois Public Aid Code, to ensure |
8 | | the delivery of pediatric palliative care services. |
9 | | (305 ILCS 60/40)
|
10 | | Sec. 40. Administration. |
11 | | (a) The Department shall oversee the administration of the |
12 | | pilot program. The Department, in consultation with interested |
13 | | stakeholders, shall determine the appropriate process for |
14 | | review of referrals and enrollment of qualifying participants. |
15 | | (b) The Department shall appoint an individual or entity to |
16 | | serve as case manager or an alternative position to assess |
17 | | level-of-care and target-population criteria for the pilot |
18 | | program. The Department shall ensure that the individual or |
19 | | entity meets the criteria for demonstrated expertise in |
20 | | pediatric palliative care that the Department, in consultation |
21 | | with interested stakeholders, may establish by rule receives |
22 | | pediatric End-of-Life Nursing Education Curriculum (Pediatric |
23 | | ELNEC Training) or an equivalent to become familiarized with |
24 | | the unique needs and difficulties facing this population . The |
|
| | 10100SB1105sam001 | - 11 - | LRB101 06383 KTG 59330 a |
|
|
1 | | process for review of referrals and enrollment of qualifying |
2 | | participants shall not include unnecessary delays and shall |
3 | | reflect the fact that treatment of pain and other distressing |
4 | | symptoms represents an urgent need for children with a serious |
5 | | illness life-limiting medical conditions . The process shall |
6 | | also acknowledge that children with a serious illness |
7 | | life-limiting medical conditions and their families require |
8 | | holistic and seamless care.
|
9 | | (Source: P.A. 96-1078, eff. 7-16-10.) |
10 | | (305 ILCS 60/45)
|
11 | | Sec. 45. Report. Period of pilot program. After the program |
12 | | has been in place for 3 years, the Department shall prepare a |
13 | | report for the General Assembly concerning the program's |
14 | | outcomes effectiveness and shall also make recommendations for |
15 | | program improvement, including, but not limited to, the |
16 | | appropriateness of those serious illnesses that render a |
17 | | pediatric medical assistance receipt eligible for the program |
18 | | as defined in subsection (b) of Section 25 and the necessary |
19 | | services needed to ensure high-quality care for children and |
20 | | their families. |
21 | | (a) The program implemented under this Act shall be |
22 | | considered a pilot program for 3 years following the date of |
23 | | program implementation or, if the pilot program is created |
24 | | utilizing a waiver authority, until the waiver that includes |
25 | | the services provided under the program undergoes the federally |
|
| | 10100SB1105sam001 | - 12 - | LRB101 06383 KTG 59330 a |
|
|
1 | | mandated renewal process. |
2 | | (b) During the period of time that the waiver program is |
3 | | considered a pilot program, pediatric palliative care shall be |
4 | | included in the issues reviewed by the Hospice and Palliative |
5 | | Care Advisory Board. The Board shall make recommendations |
6 | | regarding changes or improvements to the program, including but |
7 | | not limited to advisement on potential expansion of the |
8 | | potentially life-limiting medical conditions as defined in |
9 | | subsection (b) of Section 25. |
10 | | (c) At the end of the 3-year pilot program, the Department |
11 | | shall prepare a report for the General Assembly concerning the |
12 | | program's outcomes effectiveness and shall also make |
13 | | recommendations for program improvement, including, but not |
14 | | limited to, the appropriateness of the potentially |
15 | | life-limiting medical conditions as defined in subsection (b) |
16 | | of Section 25.
|
17 | | (Source: P.A. 96-1078, eff. 7-16-10.)
|
18 | | (305 ILCS 60/3 rep.) |
19 | | Section 10. The Pediatric Palliative Care Act is amended by |
20 | | repealing Section 3.".
|